126 related articles for article (PubMed ID: 30821940)
1. [The physiologic and pathophysiologic role of stimulating growth factor ST2.].
Dyleva YA; Gruzdeva OV; Akbasheva OE; Uchasova EG; Barbarash OL
Klin Lab Diagn; 2017; 62(10):599-605. PubMed ID: 30821940
[TBL] [Abstract][Full Text] [Related]
2. The biology of ST2: the International ST2 Consensus Panel.
Pascual-Figal DA; Januzzi JL
Am J Cardiol; 2015 Apr; 115(7 Suppl):3B-7B. PubMed ID: 25665766
[TBL] [Abstract][Full Text] [Related]
3. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
4. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
[TBL] [Abstract][Full Text] [Related]
5. ST2 Signaling in the Tumor Microenvironment.
Chang CP; Hu MH; Hsiao YP; Wang YC
Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
[TBL] [Abstract][Full Text] [Related]
6. Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.
Veeraveedu PT; Sanada S; Okuda K; Fu HY; Matsuzaki T; Araki R; Yamato M; Yasuda K; Sakata Y; Yoshimoto T; Minamino T
Biochem Pharmacol; 2017 Aug; 138():73-80. PubMed ID: 28450225
[TBL] [Abstract][Full Text] [Related]
7. Soluble ST2--analytical considerations.
Mueller T; Jaffe AS
Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
[TBL] [Abstract][Full Text] [Related]
8. The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation.
Brunetti G; Barile B; Nicchia GP; Onorati F; Luciani GB; Galeone A
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371771
[TBL] [Abstract][Full Text] [Related]
9. Soluble ST2: A complex and diverse role in several diseases.
Homsak E; Gruson D
Clin Chim Acta; 2020 Aug; 507():75-87. PubMed ID: 32305537
[TBL] [Abstract][Full Text] [Related]
10. IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic Asthmatics.
Mitchell PD; Salter BM; Oliveria JP; El-Gammal A; Tworek D; Smith SG; Sehmi R; Gauvreau GM; O Apos Byrne PM
Int Arch Allergy Immunol; 2018; 176(2):133-142. PubMed ID: 29694974
[TBL] [Abstract][Full Text] [Related]
11. A role for soluble ST2 in vascular remodeling associated with obesity in rats.
Martínez-Martínez E; Miana M; Jurado-López R; Rousseau E; Rossignol P; Zannad F; Cachofeiro V; López-Andrés N
PLoS One; 2013; 8(11):e79176. PubMed ID: 24265755
[TBL] [Abstract][Full Text] [Related]
12. The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment.
Willems S; Hoefer I; Pasterkamp G
Minerva Med; 2012 Dec; 103(6):513-24. PubMed ID: 23229370
[TBL] [Abstract][Full Text] [Related]
13. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.
Bartunek J; Delrue L; Van Durme F; Muller O; Casselman F; De Wiest B; Croes R; Verstreken S; Goethals M; de Raedt H; Sarma J; Joseph L; Vanderheyden M; Weinberg EO
J Am Coll Cardiol; 2008 Dec; 52(25):2166-74. PubMed ID: 19095135
[TBL] [Abstract][Full Text] [Related]
14. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
Sweet MJ; Leung BP; Kang D; Sogaard M; Schulz K; Trajkovic V; Campbell CC; Xu D; Liew FY
J Immunol; 2001 Jun; 166(11):6633-9. PubMed ID: 11359817
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of sST2 in cardiac diseases.
Pascual-Figal DA; Lax A; Perez-Martinez MT; del Carmen Asensio-Lopez M; Sanchez-Mas J;
Clin Chem Lab Med; 2016 Jan; 54(1):29-35. PubMed ID: 26544104
[TBL] [Abstract][Full Text] [Related]
16. An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.
O'Donnell C; Mahmoud A; Keane J; Murphy C; White D; Carey S; O'Riordain M; Bennett MW; Brint E; Houston A
Br J Cancer; 2016 Jan; 114(1):37-43. PubMed ID: 26679377
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of soluble ST2 in cardiology.
Dudek M; Kałużna-Oleksy M; Migaj J; Straburzyńska-Migaj E
Adv Clin Exp Med; 2020 Oct; 29(10):1205-1210. PubMed ID: 33049127
[TBL] [Abstract][Full Text] [Related]
18. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel.
Januzzi JL; Mebazaa A; Di Somma S
Am J Cardiol; 2015 Apr; 115(7 Suppl):26B-31B. PubMed ID: 25665762
[TBL] [Abstract][Full Text] [Related]
19. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction.
Asensio-Lopez MC; Lax A; Fernandez Del Palacio MJ; Sassi Y; Hajjar RJ; Januzzi JL; Bayes-Genis A; Pascual-Figal DA
J Mol Cell Cardiol; 2019 May; 130():216-233. PubMed ID: 30998979
[TBL] [Abstract][Full Text] [Related]
20. Role of the IL-33/ST2L axis in colorectal cancer progression.
Akimoto M; Takenaga K
Cell Immunol; 2019 Sep; 343():103740. PubMed ID: 29329638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
